Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

• Nishan Tchekmedyian, MD,
• Bill Paxton, MD, PhD,
• Francois Lebel, MD,
• Lena Keossayan, BA,
• John V. Heymach, MD, PhD

Affiliations

Nishan Tchekmedyian, MD

Pacific Shores Medical Group, Huntington Beach, California; Corresponding author. Address for correspondence: Nishan Tchekmedyian, MD, Pacific Shores Medical Group, 19582 Beach Blvd. #212, Huntington Beach, CA 92648.

Bill Paxton, MD, PhD

Spectrum Pharmaceuticals, Irvine, California

Francois Lebel, MD

Spectrum Pharmaceuticals, Irvine, California

Lena Keossayan, BA

Pacific Shores Medical Group, Huntington Beach, California

John V. Heymach, MD, PhD

Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas